logo
COVID-19 vaccination and sudden death among young adults: Baseless claim will hamper vaccinations, says National Institute of Epidemiology Director

COVID-19 vaccination and sudden death among young adults: Baseless claim will hamper vaccinations, says National Institute of Epidemiology Director

The Hindu02-07-2025
COVID-19 vaccination did not increase the risk of unexplained sudden death among young adults, Manoj V. Murhekar, Director, India Council of Medical Research (ICMR)-National Institute of Epidemiology (NIE), told The Hindu on Wednesday (July 2, 2025), adding that their research had indicated other contributing factors, including genetic make-up, binge drinking, COVID-19 hospitalisation, and vigorous intensity physical activity.
'Past COVID hospitalisation, a family history of sudden death, and certain lifestyle behaviours increased the likelihood of sudden deaths [in young adults],' Dr. Murhekar said, adding that research had, in fact, indicated the positive effect of vaccination.
There was no urgency or need for the reintroduction of the COVID-19 vaccine as a booster dose now, Dr. Murhekar said. 'As of now, we aren't seeing any major spikes in COVID cases, and there are no trends indicating the need for booster doses. We also know that newer variants are escaping vaccination cover so we need not rush into getting booster doses as of now,' he said.
Baseless linking of COVID-19 vaccination to sudden deaths could hamper the vaccination programmes for other diseases, he cautioned. 'It is easy to blame vaccination without any scientific basis but the negative impact it has on the overall acceptance and adherence to vaccination trial participations and use suffers,' Dr. Murhekar said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

New COVID variant Stratus (XFG) spreads in the US: Symptoms, risks, and what you need to know
New COVID variant Stratus (XFG) spreads in the US: Symptoms, risks, and what you need to know

Time of India

time6 hours ago

  • Time of India

New COVID variant Stratus (XFG) spreads in the US: Symptoms, risks, and what you need to know

As the United States experiences another wave of COVID-19, a variant named Stratus (XFG) has caught the attention of health authorities. Officially identified as XFG, this recombinant strain was first detected in Southeast Asia in January 2025. While initially flying under the radar in the US, XFG accounted for 14% of all cases by late June, making it the third most prevalent variant according to the Centers for Disease Control and Prevention (CDC). Globally, the World Health Organization ( WHO ) has added XFG to its monitoring list, though it continues to classify the variant's overall public health risk as low. Experts reassure that current COVID-19 vaccines remain effective against symptomatic and severe disease caused by this strain. What is the new covid variant in the US Stratus (XFG) and how is it different XFG is a recombinant variant, meaning it combines genetic material from two earlier strains: F.7 and LP.8.1.2. While LP.8.1.2 is now the second most common strain in the US, XFG is notable for its mutations that may help it evade the immune system. Importantly, experts emphasize that these mutations do not make XFG more dangerous. According to Dr. Subhash Verma, microbiology and immunology professor at the University of Nevada, XFG does not cause more severe illness or different symptoms compared to earlier Omicron variants. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Use an AI Writing Tool That Actually Understands Your Voice Grammarly Install Now Undo Health authorities classify the variant as low risk, but continued monitoring is essential to track its evolution. How fast is this covid variant As reported by USA Today, XFG's prevalence in the US has increased rapidly in recent months: March 2025: 0% of cases April 2025: 2% of cases May 2025: 6% of cases Late June 2025: 14% of cases Globally, the WHO reported a rise from 7.4% in early May to 22.7% by the end of June across 38 countries. Despite this growth, XFG has not surpassed the top two variants, but its upward trend underscores the importance of ongoing genomic surveillance and vaccine coverage. Symptoms of Stratus (XFG) variant As USA Today reported, know the familiar COVID-19 symptoms for XFG infections. These include: Fever or chills Cough Fatigue Sore throat Loss of taste or smell Nasal congestion Muscle aches Shortness of breath Headache Nausea or vomiting Health officials stress that symptom patterns remain consistent with prior Omicron variants, and early testing, vaccination, and isolation are key to controlling spread. Prevention tips for Stratus (XFG) variant To reduce the risk of infection from the XFG variant (Stratus), follow these recommended safety measures: Stay up to date with COVID-19 vaccines: Ensure primary doses and booster shots are current, as vaccines remain effective against severe disease. Practice good hygiene: Regular handwashing, using hand sanitizer, and avoiding touching the face can reduce transmission. Wear masks in crowded or enclosed spaces: Especially in public transport, healthcare facilities, or areas with high case counts. Maintain physical distancing: Avoid close contact with people showing respiratory symptoms. Monitor symptoms and test early: Get tested if you experience fever, cough, fatigue, or other COVID-related symptoms. Isolate if infected: Follow local health guidelines to prevent spreading the virus to others. Ventilate indoor spaces: Increase airflow in homes, offices, and public spaces to reduce viral concentration. Disclaimer : The information provided in this article is for general educational purposes only and is based on data available from the reputable news sources as of August 2025. It should not be considered medical advice. Always consult healthcare professionals for personal guidance on COVID-19 prevention, testing, and treatment. Also read | Sudden cardiac arrest in gyms: Causes, prevention tips, and urgent advisory issued for young athletes by Punjab government

ICMR study flags unregulated herbal tobacco products on e-commerce sites
ICMR study flags unregulated herbal tobacco products on e-commerce sites

Indian Express

time7 hours ago

  • Indian Express

ICMR study flags unregulated herbal tobacco products on e-commerce sites

A new study has found that herbal cigarettes, often marketed as 'safer alternatives,' produce harmful combustion products that are similar to those found in tobacco cigarettes. The affordability and digital accessibility of these products, combined with misleading health claims, pose significant risks to tobacco users seeking genuine cessation support, said researchers from Indian Council of Medical Research (ICMR)-National Institute of Cancer Prevention and Research. Dr Prashant Kumar Singh, lead author and scientist, ICMR-National Institute of Cancer Prevention and Research, said that their study, published in the journal Tobacco Control, found at least 316 unverified herbal products targeting tobacco users across major Indian e-commerce platforms. 'Herbal tobacco cessation products (HTCPs), marketed with claims to support tobacco or nicotine cessation, are increasingly sold online in low and middle-income countries. However, there is little regulatory oversight or evidence on their safety and effectiveness. This study assessed the availability, affordability, claims and regulation of HTCPs on Indian e-commerce platforms,' Dr Singh told The Indian Express. In India, as per the report, there are approximately 266.8 million users of tobacco, the majority of whom consume smokeless tobacco products. Despite substantial progress in tobacco control, the reach of cessation services remains uneven across different population groups. According to the study authors, recent studies indicate that HTCPs are increasingly being used by young adults and the regulatory landscape for these products remains fragmented. HTCPs encompass a broad category of formulations—including herbal capsules, lozenges, gutkha substitutes, powders and herbal smokes—claimed as natural, safer alternatives to conventional pharmacotherapy. According to Dr Singh, these products are increasingly available on digital platforms, where vendors often make therapeutic claims such as 'eliminates cravings,' 'detoxifies lungs,' or 'replaces gutkha safely'. Researchers searched some of the major Indian e-commerce platforms, screened product listings and categorised product type, claimed indications, presence of disclaimers, regulatory approvals and pricing. 'We were able to identify 316 unique HTCPs across some of the major Indian e-commerce platforms,' he said. The study showed that HTCPs were marketed in three primary formulations: combustible products (42.7 per cent), raw herbal preparations (34.5 per cent) and other formats such as gummies, drops, capsules and patches (22.8 per cent). Products featured diverse flavours and varied widely in pricing. 'Our verification of regulatory claims through official databases adds credibility to the findings,' Dr Singh said. According to the study findings, only 23 per cent of products with AYUSH claims and 15 per cent with Central Drugs Standard Control Organisation (CDSCO) claims could be verified through official databases. Of the 316 HTCPs, 197 (62.3 per cent) reported at least one form of certification claim. Additionally, 43.7 per cent of products promoted ancillary health claims such as detoxification or anxiety relief. Only 12 of the products displayed age restrictions, and none had functional age verification mechanisms. A small fraction (0.5 per cent) referenced World Health Organization (WHO) affiliation, raising concerns about potentially misleading endorsements. The authors urged e-commerce platforms to implement mandatory health claims verification and functional age-restriction protocols. They added that all products must undergo testing in accredited facilities, such as the National Tobacco Testing Laboratories.

What your cough says about your health: Spot the difference between dry, wet, and wheezing
What your cough says about your health: Spot the difference between dry, wet, and wheezing

Time of India

time7 hours ago

  • Time of India

What your cough says about your health: Spot the difference between dry, wet, and wheezing

Coughing is more than a minor annoyance; it can reveal important clues about your health. According to a study published in PLOS One, understanding whether your cough is dry, wet, or wheezing helps identify its cause, from viral or bacterial infections to asthma or lingering post-infection irritation. A dry cough is often persistent and hacking, while wet coughs produce mucus, and wheezing signals potential breathing difficulties. Recognising these differences can guide treatment choices, self-care, and when to seek medical attention. By learning what your cough says about your body, you can act early, protect your lungs, and prevent serious complications. Different types of cough : How to spot viral, bacterial, and lingering coughs Viral cough A viral cough is typically dry, persistent, and sometimes painful. It often comes on suddenly and is caused by viral infections such as the flu, the common cold, or COVID-19. Unlike bacterial infections, a viral cough usually doesn't produce thick mucus. Cough suppressants may provide relief, but expectorants, medications that help clear mucus, are generally ineffective in this case. While uncomfortable, viral coughs often resolve on their own within a week or two. Bacterial cough A bacterial cough is generally wetter, producing yellow or green mucus. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Benefits of Trading Bitcoin CFDs IC Markets Learn More This type of cough can signal bacterial infections like bronchitis or pneumonia. If left untreated, it can escalate to serious complications. Antibiotics are typically required to tackle the underlying infection, while expectorants and adequate hydration can ease symptoms. The colour of the mucus is an important clue: yellow or green usually indicates bacteria, whereas clear mucus points toward a viral cause. Whooping cough Whooping cough, or pertussis, is a severe bacterial infection caused by Bordetella pertussis. It is marked by intense coughing fits followed by a high-pitched 'whoop' when inhaling. This condition can be particularly dangerous for infants and young children, so prompt medical treatment is crucial. Vaccination remains the most effective preventive measure, but early intervention with antibiotics is essential for those infected. Post-infection cough Sometimes, coughing persists long after the initial infection has cleared. This post-infection cough can be phlegmy and lingering, especially in smokers or people with underlying lung conditions. Though usually not dangerous, it can be disruptive and may even become chronic in some cases. Remedies like herbal teas, steam inhalation, and gentle expectorants can provide temporary relief while the airways fully recover. Not all coughs need immediate medical attention, but certain warning signs should not be ignored. If your cough persists for more than a few weeks, produces thick yellow or green mucus, or is accompanied by fever, chest pain, or difficulty breathing, consult a healthcare professional. Prompt evaluation can help prevent serious complications and ensure appropriate treatment. Wet vs. dry cough: How to tell the difference A simple way to differentiate coughs is by checking for mucus. Wet coughs produce mucus or phlegm and are often linked to infections in the lungs or airways. Dry coughs, on the other hand, don't produce mucus and are commonly associated with viral infections, allergies, or irritants like smoke and dust. Understanding this distinction can guide treatment choices and self-care measures. Mucus colour and what it reveals about your cough The colour of your mucus can provide additional clues about the cause of your cough. Clear or white mucus usually points to viral infections or mild irritation, while yellow or green mucus suggests a bacterial infection that may require antibiotics. Monitoring changes in mucus colour and consistency can help you track the progression of your illness and decide when to seek medical help. Wheezing and asthma: When coughing signals a serious issue A wheezing cough, a high-pitched, whistling sound during breathing, can indicate asthma or other bronchial conditions. Asthma-related coughing may be triggered by allergens, exercise, or respiratory infections. If wheezing is frequent or accompanied by shortness of breath, it's important to see a doctor for diagnosis and treatment. Asthma medications, including inhalers, can manage symptoms and prevent severe breathing difficulties. While most coughs resolve on their own, ignoring persistent symptoms can be dangerous. Bacterial infections can progress to pneumonia, while untreated asthma may lead to severe respiratory complications. Chronic coughing can also strain the chest muscles, disrupt sleep, and reduce overall quality of life. Recognising the underlying cause early helps prevent these complications and ensures proper care. Treatment depends on the type of cough and its cause. Dry coughs may respond well to cough suppressants, while wet coughs benefit from expectorants, staying hydrated, and resting the lungs. For asthma-related coughs, inhalers and other prescribed medications are essential. Supportive care, such as warm fluids, humidified air, and avoiding irritants like smoke, can also help alleviate symptoms. Also Read: 11 signs your blood sugar is too high: Spot the warning symptoms early

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store